Comprehensive review of solid tumor bone marrow metastasis
L Zhang, F Chen, L Xu, N Li, Q Zhuo, Y Guo… - Critical Reviews in …, 2024 - Elsevier
Bone marrow metastasis (BMM) of solid tumors refers to a group of diseases that originate
from non-hematopoietic malignant tumor cells invading the bone marrow (BM) through …
from non-hematopoietic malignant tumor cells invading the bone marrow (BM) through …
Mechanism and clinical progression of solid tumors bone marrow metastasis
R Yang, L Jia, J Cui - Frontiers in Pharmacology, 2024 - frontiersin.org
The rich blood supply of the bone marrow provides favorable conditions for tumor cell
proliferation and growth. In the disease's early stages, circulating tumor cells can escape to …
proliferation and growth. In the disease's early stages, circulating tumor cells can escape to …
Multi-omics analysis of the tumor microenvironment in liver metastasis of colorectal cancer identified FJX1 as a novel biomarker
J Zou, H Zhang, Y Huang, W Xu, Y Huang, S Zuo… - Frontiers in …, 2022 - frontiersin.org
Colorectal cancer incidence and mortality have increased in recent years, with more than
half of patients who died of colorectal cancer developing liver metastases. Consequently …
half of patients who died of colorectal cancer developing liver metastases. Consequently …
[HTML][HTML] Joint effect of RRP9 and DDX21 on development of colorectal cancer and keloid
H Liu, X Chi, N Yang, M Shan, Y Xiao, M Zhang… - Aging (Albany …, 2023 - ncbi.nlm.nih.gov
Background: Colorectal cancer (CRC) is a common malignancy in the gastrointestinal tract.
Keloid refers to abnormal scar tissue that forms on the skin or mucous membrane. The …
Keloid refers to abnormal scar tissue that forms on the skin or mucous membrane. The …
RRP9 and DDX21 as new biomarkers of colorectal cancer
X Chi, N Yang, Y Liu - Medicine, 2023 - journals.lww.com
Colorectal cancer originates from the epithelium of the large intestine and is a common
malignant tumor in the gastrointestinal tract. However, the relationship between RRP9 and …
malignant tumor in the gastrointestinal tract. However, the relationship between RRP9 and …
Long-term stable disease with mFOLFOX6 chemotherapy plus cetuximab for bone marrow metastasis from rectal cancer: A case report
X Fan, F Li, C Xiao, Y Cai, F You - Frontiers in Oncology, 2023 - frontiersin.org
Bone marrow metastasis from rectal cancer is a rare but severe disease associated with a
poor prognosis due to limited treatment options. There is no consensus on therapeutic …
poor prognosis due to limited treatment options. There is no consensus on therapeutic …
[PDF][PDF] 瑞戈非尼联合PD-1 制剂治疗复发转移性结直肠癌的临床疗效观察
孔羽， 熊勇， 刘俊， 何丽 - 中国当代医药, 2023 - dangdaiyiyao.com
目的探讨瑞戈非尼联合程序性细胞死亡受体1 (PD-1) 制剂治疗复发转移性结直肠癌的临床效果.
方法选取2022 年1 月至6 月新余市人民医院肿瘤科收治的50 例复发转移性结直肠癌的患者 …
方法选取2022 年1 月至6 月新余市人民医院肿瘤科收治的50 例复发转移性结直肠癌的患者 …
[HTML][HTML] Occult colon cancer with sepsis as the primary manifestation identified by bone marrow puncture: A case report
HJ Wang, CJ Zhou - World Journal of Clinical Cases, 2022 - ncbi.nlm.nih.gov
BACKGROUND Bone marrow metastasis is common in liver and lung cancer, but there are
few reports on bone marrow metastasis in colon cancer. To date, there are no such reports …
few reports on bone marrow metastasis in colon cancer. To date, there are no such reports …